Skip to main content
Journal cover image

China-United States Research Collaborations in Antimicrobial Resistance.

Publication ,  Journal Article
van Duin, D; Gu, P; Dong, J; Paff, M; Arias, RM; Evans, B; Yu, Y; Li, L; Zhang, F; Liu, Z; Cao, B; Fowler, VG; Wang, M
Published in: Clin Infect Dis
November 13, 2018

A strong synergy can result from China-US antimicrobial resistance (AMR) collaborations given similarities and differences between their respective healthcare systems and research infrastructures. The Antibacterial Resistance Leadership Group has employed a model of realistic growth, starting with a feasible, relatively low-resource observational study in a critical priority pathogen. This and other observational studies will provide vital scientific information required for the rational design of future interventional trials. In addition, it provides a mutual, low-risk opportunity for determining the strengths and opportunities of the research collaboration. Issues identified during the observational studies can be addressed prior to the initiation of high-resource interventional studies. Collaborative clinical AMR studies between China and the United States have tremendous potential to decrease AMR rates, improve responsible antibiotic use, and ultimately improve the lives of patients in both countries.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

November 13, 2018

Volume

67

Issue

suppl_2

Start / End Page

S142 / S145

Location

United States

Related Subject Headings

  • United States
  • Public-Private Sector Partnerships
  • Observational Studies as Topic
  • Microbiology
  • Internationality
  • Humans
  • Drug Resistance, Multiple, Bacterial
  • Delivery of Health Care
  • Clinical Trials as Topic
  • China
 

Citation

APA
Chicago
ICMJE
MLA
NLM
van Duin, D., Gu, P., Dong, J., Paff, M., Arias, R. M., Evans, B., … Wang, M. (2018). China-United States Research Collaborations in Antimicrobial Resistance. Clin Infect Dis, 67(suppl_2), S142–S145. https://doi.org/10.1093/cid/ciy694
Duin, David van, Peidi Gu, Jane Dong, Melanie Paff, Rebekka M. Arias, Beth Evans, Yunsong Yu, et al. “China-United States Research Collaborations in Antimicrobial Resistance.Clin Infect Dis 67, no. suppl_2 (November 13, 2018): S142–45. https://doi.org/10.1093/cid/ciy694.
van Duin D, Gu P, Dong J, Paff M, Arias RM, Evans B, et al. China-United States Research Collaborations in Antimicrobial Resistance. Clin Infect Dis. 2018 Nov 13;67(suppl_2):S142–5.
van Duin, David, et al. “China-United States Research Collaborations in Antimicrobial Resistance.Clin Infect Dis, vol. 67, no. suppl_2, Nov. 2018, pp. S142–45. Pubmed, doi:10.1093/cid/ciy694.
van Duin D, Gu P, Dong J, Paff M, Arias RM, Evans B, Yu Y, Li L, Zhang F, Liu Z, Cao B, Fowler VG, Wang M. China-United States Research Collaborations in Antimicrobial Resistance. Clin Infect Dis. 2018 Nov 13;67(suppl_2):S142–S145.
Journal cover image

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

November 13, 2018

Volume

67

Issue

suppl_2

Start / End Page

S142 / S145

Location

United States

Related Subject Headings

  • United States
  • Public-Private Sector Partnerships
  • Observational Studies as Topic
  • Microbiology
  • Internationality
  • Humans
  • Drug Resistance, Multiple, Bacterial
  • Delivery of Health Care
  • Clinical Trials as Topic
  • China